Clik here to view.
Organovo launches bio-printed kidney tissue service
Organovo (PINK:ONVO), the contract research organization known for their 3D bio-printed liver tissue, announced today that it began commercial contracting for its second tissue service, the ExVive...
View ArticleClik here to view.
Apollo Endosurgery, Lpath ink reverse merger
Apollo Endosurgery and Lpath Inc. (NSDQ:LPTN) said yesterday that they inked a reverse merger agreement that will see Apollo’s owners become majority owners of the pharmaceutical company. Apollo plans...
View ArticleClik here to view.
FDA issues UDI compliance extension for certain Class II devices
By David Lennarz, Vice President and Co-Founder of Registrar Corp On September 6, 2016, the U.S. Food and Drug Administration (FDA) issued an extension to the Unique Device Identification (UDI)...
View ArticleClik here to view.
Sanofi, Google’s Verily launch $500m Onduo diabetes JV
Sanofi (NYSE:SNY) and Verily Life Sciences, the healthcare play owned by Google parent Alphabet (NSDQ:GOOGL), are launching a joint venture to tackle diabetes. The Cambridge, Mass.-based Onduo JV will...
View ArticleClik here to view.
Acelity CFO Casey departs on the eve of $1.75B debt offering, $450m refi
UPDATED Sept. 13, 2016, with details on Casey’s move to Lending Club. Acelity CFO Tom Casey is stepping down effective Sept. 16 for the chief finance spot at Lending Club, as Acelity prepares for a...
View ArticleClik here to view.
Teva plans competitor for Mylan’s EpiPen
Teva Pharmaceutical (NYSE:TEVA) said last week that it hopes to win U.S. approval for its version of Mylan‘s (NSDQ:MYL) EpiPen by late 2017 or early 2018. Mylan’s EpiPen holds an estimated 94% market...
View ArticleClik here to view.
Resonetics plans Minnesota laser micro-manufacturing plant
Resonetics said today it is opening a laser micro-manufacturing facility in Plymouth, Minn. Get the full story at our sister site, Medical Design & Outsourcing. The post Resonetics plans...
View ArticleClik here to view.
Appeals court overturns triple damages in Zimmer Biomet’s $280m patent loss...
A federal appeals court today overturned the enhanced damages and attorney fees awarded in Stryker‘s (NYSE:SYK) $70 million patent infringement win over Zimmer Biomet (NYSE:ZBH), but upheld its prior...
View ArticleClik here to view.
Terumo, CytoSorbents ink cardiac surgery deal
Terumo Corp. (TYO:4543) said today it inked a strategic partnership deal with CytoSorbents to commercialize its CytoSorb blood purification adsorber for cardiac surgery applications. New Jersey-based...
View ArticleClik here to view.
Private equity player Vance Street Capital acquires Motion Dynamics
Private equity player Vance Street Capital said it invested an unspecified amount in Motion Dynamics Corp. and its wire-based components business. Los Angeles-based Vance Street said Motion Dynamics is...
View ArticleClik here to view.
Biotronik touts dual drug-coated balloon-stent therapy for lower-limb disease
Biotronik today released data from studies of its Pulsar-18 bare metal self-expanding stent and Passeo-18 Lux drug-coated ballon, touting high rates or primary patency and freedom from target lesion...
View ArticleClik here to view.
AstraZeneca, Bespak ink deal for metered-dose inhaler
AstraZeneca (NYSE:AZN) said last week that it inked a multi-year commercial supply deal with Consort Medical (LON:CSRT) subsidiary Bespak for its pressurized metered-dose inhaler technology. Bespak...
View ArticleClik here to view.
Novocure touts long-term analysis of Optune drug-device combo
Novocure (NSDQ: NVCR) touted a long-term analysis of data from a Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-formed glioblastomas. Survival...
View ArticleClik here to view.
Chemists develop 3D bone-scanning technique
Chemists at Trinity College Dublin created a 3D bone-scanning technique that does not expose patients to radiation. The team attached a luminescent tag to tiny, gold structures called nanoagents. The...
View ArticleClik here to view.
Nordisk issues voluntary recall of GlucaGen HypoKits
Novo Nordisk (NYSE:NVO) issued a voluntary recall of 6 batches of its GlucaGen HypoKits in the U.S., after reports of detached needles in the syringes. The company initiated the recall following 2...
View ArticleClik here to view.
Coapt looks to bring prosthetic electrodes into the 21st century
When Jodie O’Connell-Ponkos was 16, she lost her right arm in a meat-grinding accident.* She was given a prosthesis, but quickly came to hate it. It was a standard myoelectric system, using a pair of...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
FDA OKs expanded trial for Precision Biopsy’s ClariCore prostate biopsy device
Precision Biopsy said today it won an investigational device exemption from the FDA to expand the trial of its ClariCore biopsy system, now looking to enroll prostate cancer patients in the newly...
View ArticleClik here to view.
Survey: The Fractured State of Enterprise Sales Enablement and Training
According to a recent Allego survey, 73% of salespeople in the medical/pharmaceutical industry believe insights from reps in the field would improve the sales enablement process at their company....
View ArticleClik here to view.
Orthofix launches study of pulsed electromagnetic fields in treating...
Orthofix (NSDQ:OFIX) said today it enrolled the 1st patient in a study exploring the use of its Physio-Stim pulsed electromagnetic field system for treating osteoarthritis of the knee. The Lewisville,...
View Article